TABLE 3.
No radiotherapy |
Any radiotherapy |
||||||||
---|---|---|---|---|---|---|---|---|---|
ICD8 | Cause of death | n a | SMRb | 95% CIc | n a | SMRb | 95% CIc | RRd | 95% CIc |
Number of women: | 3,186 | 9,769 | |||||||
Person-years: | 101,816 | 288,589 | |||||||
10–999 | All causes | 2,191 | 0.9 | 0.8–0.9 | 7,162 | 0.9 | 0.9–0.9 | 1.1 | 1.1–1.2 |
140–199 | All solid cancers | 353 | 0.8 | 0.8–0.9 | 1,395 | 1.1 | 1.1–1.2 | 1.3 | 1.2–1.5 |
Heavily-irradiated sites (>1 Gy) | 109 | 0.7 | 0.6–0.8 | 690 | 1.4 | 1.3–1.5 | 1.9 | 1.6–2.4 | |
180–180 | Uterine cervix | 14 | 0.7 | 0.4–1.2 | 65 | 0.9 | 0.7–1.1 | 1.2 | 0.7–2.3 |
181–182 | Uterine corpus | 15 | 0.7 | 0.4–1.2 | 217 | 2.9 | 2.6–3.3 | 3.7 | 2.3–6.5 |
188 | Bladder | 5 | 0.5 | 0.2–1.1 | 48 | 1.6 | 1.2–2.1 | 3.2 | 1.4–9.2 |
154 | Rectum | 4 | 0.3 | 0.1–0.6 | 51 | 1.0 | 0.7–1.3 | 4.1 | 1.7–13.8 |
183 | Ovary | 21 | 0.8 | 0.5–1.1 | 105 | 1.3 | 1.1–1.6 | 1.8 | 1.1–3.0 |
184 | Other female genital organs | 6 | 2.0 | 0.8–4.1 | 10 | 1.1 | 0.5–1.9 | 0.6 | 0.2–1.7 |
153 | Colon | 50 | 0.8 | 0.6–1.0 | 204 | 1.1 | 0.9–1.2 | 1.4 | 1.1–2.0 |
Lightly-irradiated sites (0.1–1 Gy) | |||||||||
155–156 | Liver, gallbladder and bile ducts | 14 | 0.9 | 0.5–1.4 | 42 | 0.7 | 0.5–1.0 | 0.9 | 0.5–1.8 |
151 | Stomach | 19 | 0.8 | 0.5–1.2 | 68 | 0.8 | 0.6–1.0 | 1.0 | 0.6–1.8 |
189 | Kidney | 9 | 1.2 | 0.6–2.2 | 24 | 1.2 | 0.8–1.7 | 0.8 | 0.4–1.9 |
157 | Pancreas | 26 | 1.0 | 0.7–1.5 | 74 | 1.0 | 0.8–1.3 | 1.1 | 0.7–1.9 |
Very lightly-irradiated sites (<0.1 Gy) | |||||||||
162 | Lung | 42 | 1.0 | 0.7–1.3 | 84 | 1.0 | 0.8–1.3 | 1.1 | 0.7–1.6 |
174 | Breast | 75 | 0.9 | 0.7–1.1 | 194 | 0.8 | 0.7–1.0 | 1.0 | 0.7–1.3 |
150 | Esophagus | 1 | 0.2 | 0.0–1.0 | 10 | 0.8 | 0.4–1.4 | — e | |
193 | Thyroid | 2 | 0.9 | 0.2–2.8 | 5 | 0.7 | 0.2–1.5 | — e | |
140 | Buccal cavity and pharynx | 4 | 0.7 | 0.2–1.6 | 11 | 0.7 | 0.4–1.2 | 1.0 | 0.3–3.6 |
191 | Brain | 3 | 0.6 | 0.2–1.6 | 20 | 2.3 | 1.4–3.5 | — e | |
Bone and connective tissue cancers | |||||||||
170 | Bone | 1 | 0.5 | 0.0–2.3 | 4 | 0.6 | 0.2–1.3 | — e | |
171 | Connective tissues | 1 | 0.6 | 0.0–2.5 | 6 | 1.4 | 0.5–2.8 | — e | |
Lymphatic/Hematopoietic cancers | |||||||||
200, 202 | Non-Hodgkin lymphoma | 20 | 1.4 | 0.9–2.2 | 48 | 1.3 | 1.0–1.7 | 0.9 | 0.5–1.6 |
201 | Hodgkin lymphoma | 4 | 1.6 | 0.5–3.8 | 9 | 1.1 | 0.5–2.0 | 0.7 | 0.2–2.6 |
203 | Multiple myeloma | 8 | 1.2 | 0.5–2.2 | 18 | 1.0 | 0.6–1.6 | 0.9 | 0.4–2.1 |
204–207 | Leukemia | 10 | 0.6 | 0.3–1.1 | 70 | 1.5 | 1.1–1.8 | 2.4 | 1.3–4.9 |
204.0, 205–207 | Non-CLLf leukemia | 3 | 0.2 | 0.1–0.6 | 51 | 1.4 | 1.1–1.8 | — e | |
205 | Myeloid leukemia | 3g | 0.5 | 0.1–1.3 | 28h | 1.6 | 1.1–2.3 | — e | |
204.1, 204.9 | Lymphocytic leukemia | 7 | 1.8 | 0.8–3.7 | 19 | 1.6 | 1.0–2.5 | 0.9 | 0.4–2.3 |
Number of deaths.
Standardized mortality ratio.
95% confidence interval.
Relative risk of mortality (relative risks and 95% confidence intervals for lymphatic/hematopoietic cancers were calculated based on standardized mortality rate regression).
Relative risk and 95% confidence intervals were not presented due to small number of deaths among no RT group.
Chronic lymphocytic leukemia.
Two acute myeloid leukemia and 1 not other specified.
Twelve acute myeloid leukemia, 12 chronic myeloid leukemia and 4 not other specified.